Algert Global LLC Ocular Therapeutix, Inc Transaction History

Algert Global LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$3.14 - $5.04 $74,575 - $119,700	-23,750 Reduced 48.24%	25,480 $80,000
Q2 2023 Aug 14, 2023	BUY	$4.6 - $7.64 $226,457 - $376,117	49,230 New	49,230 $254,000
Q3 2022 Nov 15, 2022	BUY	$4.09 - $6.5 $21,717 - $34,515	5,310 Added 7.78%	73,590 $305,000
Q2 2022 Aug 15, 2022	BUY	$3.01 - $5.22 $169,833 - $294,528	56,423 Added 475.86%	68,280 $274,000
Q1 2022 May 16, 2022	BUY	$4.83 - $7.35 $57,269 - $87,148	11,857 New	11,857 $59,000

Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $62,216 - $121,907	-10,100 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $97,970 - $144,834	10,100 New	10,100 $101,000

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.